Zum Inhalt springen

Max Delbrück Center identifies B3GNT2 enzyme as target for new painkillers

Max Delbrück Center identifies B3GNT2 enzyme as target for new painkillers

On April 14, scientists published the first detailed protein map of two subtypes of pain-sensing neurons, identifying over 6,000 proteins and pinpointing the enzyme B3GNT2 as a promising target for new painkillers that could operate without the systemic side effects …